Virtual Symposium - Preventing Adverse Cardiovascular and Limb Events in High-Risk Cardiometabolic Patients with Peripheral Artery Disease: Recent Trials and Advances
Patients with diabetes and PAD, particularly those with concomitant polyvascular disease, are at a greater risk for future adverse cardiovascular and limb events.
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
Clinical Brief: What BMI Should Be Used for Metabolic Surgery?
This clinical brief, adapted from a 15th CMHC Annual meeting session, will cover a concise overview of the efficacy and safety of metabolic surgery in reducing cardiometabolic risk across BMI levels.
Category
  • CMHC
Format
  • Monograph
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
Virtual Symposium - Preventing Cardiovascular Events in High-Risk Diabetes Patients with CAD: New Insights and Developments
Diabetes increases the risk of cardiovascular and thrombotic adverse events in patients with CAD compared to patients with these conditions and no concomitant diabetes.  As such, current antiplatelet therapy to prevent adverse events in these high-risk patients may not be adequate, and several re
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
Virtual Symposium - The Challenge of Chronic Hyperkalemia in Cardiometabolic Patients: Advances and Opportunities
Hyperkalemia is a serious condition associated with increased risk of mortality and is frequently prevalent and recurrent in patients who suffer from heart failure (HF), chronic kidney disease (CKD), and/or hypertension (HTN).
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
Virtual Symposium - Optimizing Postprandial Glucose Control in Patients with Diabetes: Clinical Advances and Strategies
Current evidence supports post-prandial glucose (PPG) control as an important strategy to consider in the comprehensive management plan of individuals with diabetes.  However, managing PPG remains one of the most challenging aspects of diabetes care.
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
CMHC Masterclass On Demand: Who Best to Stem the Cardiometabolic Tsunami
While a substantial body of research demonstrates the need to address the global epidemic of metabolic syndrome, and the constellation of associated cardiometabolic risk factors simultaneously, the majority of them are still treated as separate entities.
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
CMHC Masterclass On Demand: Addressing the NAFLD / NASH Epidemic: Advances in Pathophysiology, Diagnosis and Management
The increasing rates of obesity, diabetes, and metabolic syndrome in the United States are leading to more cases NAFLD and NASH, which are now being encountered at a greater frequency in clinical practice.
Category
  • CMHC
Format
  • Conference / meeting
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
CMHC Masterclass On Demand: The Nexus of Women's Health and Cardiometabolic Risk- Implications Across the Lifespan
Metabolic syndrome and associated comorbidities, such as cardiovascular disease, obesity and type 2 diabetes, are becoming more common in women of reproductive age and beyond.
Category
  • CMHC
Format
  • Conference / meeting
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
CMHC Masterclass On Demand: The Intersection of Cardiometabolic Health and Sleep Disorders
During this Masterclass, expert faculty will discuss the links between sleep disorders and cardiometabolic health, as well as practical approaches for screening, referral, or treatment.
Category
  • CMHC
Format
  • Conference / meeting
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
Patient Case: Reducing The Risk for Adverse Events in a T2DM Patient with HFrEF, CKD, and Existing ASCVD
The advent of SGLT-2 inhibitors and GLP-1 RAs to address cardiorenal risk in patients with and without type 2 diabetes, has opened up new avenues of prevention and treatment. However, individualizing the vast amount of evidence to patient care remains challenging.
Category
  • CMHC
Format
  • Self-study / Enduring
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation

Pages